Skip to main content

Peer Review reports

From: Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasma

Original Submission
1 Oct 2022 Submitted Original manuscript
5 Oct 2022 Author responded Author comments - Ahmed Abdelazim
17 Nov 2022 Reviewed Reviewer Report
8 Dec 2022 Reviewed Reviewer Report - Guangyan Zhang
24 Dec 2022 Author responded Author comments - Ahmed Abdelazim
Resubmission - Version 2
5 Oct 2022 Submitted Manuscript version 2
26 Dec 2022 Author responded Author comments - Ahmed Abdelazim
Resubmission - Version 3
26 Dec 2022 Submitted Manuscript version 3
1 Apr 2023 Author responded Author comments - Ahmed Abdelazim
Resubmission - Version 4
1 Apr 2023 Submitted Manuscript version 4
Publishing
30 Aug 2023 Editorially accepted
21 Sep 2023 Article published 10.1186/s13065-023-01030-0

You can find further information about peer review here.

Back to article page